|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/337 | (2006.01) |
| A61K 31/519 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2694056 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12715421.9 |
| Date of filing the European patent application | 2012-04-02 | |
| (97) | Date of publication of the European application | 2014-02-12 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-16 |
| (46) | Date of publication of the claims translation | 2019-12-10 |
| (86) | Number | PCT/GB2012/050736 |
| Date | 2012-04-02 |
| (87) | Number | WO 2012/131399 |
| Date | 2012-10-04 |
| (30) | Number | Date | Country code |
| 201161470668 P | 2011-04-01 | US |
| (72) |
DAVIES, Barry, Robert, GB
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Terapinis gydymas |
| THERAPEUTIC TREATMENT |
| Payment date | Validity (years) | Amount | |
| 2025-03-19 | 14 | 289.00 EUR |
| 2026-04-02 |